JCXH-105

· Immorna Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JCXH-105, covering 2024-09-19 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine [Phase 2]